|
|
This week I am delighted to announce the 31 companies that will be presenting at our first annual Invest in BC presented by Lumira Ventures. This virtual summit gives our investor-ready companies, all seeking future strategic partners, access to a global audience of over 100 investors and government representatives from 31 countries. During the two-day event, entrepreneurs will be able to tell their stories and solicit feedback from a wide range of investor stakeholders. I wish them all success.
|
|
In my inbox this week, the Research Universities Council of BC newsletter considers the role of universities and the Provincial economy. They note that among the G7, Canada is the only country with a declining rate of investment in R&D as a percentage of GDP. The outcome could be dire.
“ For BC to continue to attract foreign investment, and for our BC startups to remain local while scaling up to become global anchor companies, they will increasingly need ever more skilled, high-level talent as well as investment capital and exceptional leaders. In the new economy, people don’t just go to where companies are—companies go to where talent is.” Quote retrieved from the Research Universities' Council of BC Newsletter, issued October 8th, 2021.
Another LSBC member, BioTalent Canada is also sounding the alarm; Canada’s bio-economy is facing a labour shortage. In a press release for the newly published Labour Market Indicator study, BioTalent Canada notes that, “…national data and analysis suggests the growing bio-economy sector will need as many as 65,000 additional workers by 2029 to meet demand, and current forecasts show the talent pipeline to be three-quarters empty.”
It seems even more appropriate to congratulate our academic partners on their achievements in the Maclean’s University Rankings this year and recognize their role in preparing the life science innovators of tomorrow. Our Showcase Series supporters, University of Victoria and University of Northern BC gained joint top comprehensive university (alongside Simon Fraser University) and top primarily undergraduate institution respectively. The University of British Columbia ranked number 2 overall.
Next week, on Friday, October 22, I will be taking part in the 21st Annual Healthcare Summit, speaking alongside LSBC Board Director, David Helliwell of Thrive Health on the Consumer Engaged Healthcare panel.
-Wendy and the LSBC team
|
|
|
|
With rapid changes in the global economy, BC cannot afford to be complacent. We cannot continue to rely solely on our rich natural endowment as a source of wealth and an attractor of talent. It is increasingly urgent for us to modernize our economy to retain the standard of living we currently enjoy. READ MORE
|
|
|
|
RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Kunihiko Suzuki has agreed to accept an appointment as a Senior Strategic Advisor to its Board of Directors with a particular focus on building the Company’s enterprise in Japan. READ MORE
|
|
|
|
Roche announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® on disability progression in relapsing multiple sclerosis and primary progressive MS, as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. READ MORE
|
|
|
|
Izotropic Corporation, a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers provides updates on Q3 Milestones achieved as scheduled, including 3D imaging reconstruction software implementation, mechanical and electrical design, and clinical study design, an IzoView engineering update and meetings with Starfish Medical. READ MORE
|
|
|
|
InMed Pharmaceuticals Inc., a leader in the manufacturing and clinical development of rare cannabinoids, today announced that they have completed the previously announced acquisition of BayMedica Inc., a private company based in the US specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. READ MORE
|
|
|
|
Canada’s bio-economy is facing a severe labour shortage, with demand far exceeding supply as soon as 2024 according to a new, unprecedented labour market study released today by BioTalent Canada. The national data and analysis suggests the growing bio-economy sector will need as many as 65,000 additional workers by 2029 to meet demand, and current forecasts show the talent pipeline to be three-quarters empty. READ MORE
|
|
|
|
The boards of the Michael Smith Foundation for Health Research (MSFHR) and the BC Academic Health Science Network (BC AHSN) have signed an agreement to join forces to create a new organization, Michael Smith Health Research BC, to support the growth and evolution of BC’s health research system and life sciences sector. READ MORE
|
|
|
|
BioTalent Canada announced the kickoff of a $1.15M research study titled Building Resiliency and Sustainability for the Bio-economy to Withstand Disruption. The project, funded by the Future Skills Centre, which wraps up in September 2022, will leverage lessons learned from the pandemic to ensure long-term sustainability within Canada’s bio-economy. READ MORE
|
|
 |
Ranked among the world’s top medical schools with the fifth-largest MD enrollment in North America, the UBC Faculty of Medicine is a leader in both the science and the practice of medicine. Across British Columbia, more than 12,000 faculty and staff are training the next generation of doctors and health care professionals, making remarkable discoveries, and helping to create the pathways to better health for our communities at home and around the world.
|
|
|
|
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. They harness their deep scientific expertise to identify compounds that target the root cause of disease, advancing targeted therapies on the leading edge of cancer biology. Their team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm.
|
|
|
|
|
|
PERSPECTIVES ON GLOBAL HEALTHCARE INNOVATION |
What’s driving innovation in life science and healthcare? SVB is committed to serving the ecosystem by providing industry-leading reports featuring proprietary analysis and targeted outlooks to help companies and investors achieve their goals. Twice a year we publish deep-dive analyses describing fundraising, investment, M&A and IPO activity of private, venture-backed biopharma, medical device and diagnostic/tools companies. Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank. To find out more about Silicon Valley Bank click here. |
|
This role responds to customer inquiries and orders, prepares shipping documents, confirms orders, sends tracking info, and follows up on customer invoices / late payments and much more.
|
|
The Lab Tech III performs routine analysis of cannabis and psychedelic products as well as laboratory testing including pre- and post-analytical phases, and much more.
|
|
The Director of Oncology will provide scientific, managerial and program leadership to advance Symvivo's growing oncology pipeline.
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Peter McLoughlin - talent@lifesciencesbc.ca
|
|
|
|
|
|
|
